MANDARA Phase III data published in New England Journal of Medicine show remission is an achievable goal in eosinophilic

[Administrator]

aus dem Wall-Street-Journal:

https://www.wallstreet-online.de/nachricht/17823133-mandara-phase-iii-data-published-new-england-journal-of-medicine-show-remission-is-achievable-goal-eosinophilic-granulomatosis-with-polyangiitis-egpa-with-fasenra

alles auf Englisch